Target beefs up protein, supplement offerings, capitalizing on weight loss drug trend

Target has expanded its protein and supplement sections as GLP-1 drugs like Ozempic reshape shopping habits, driving demand ...
Seeking Alpha

Zepbound (tirzepatide) showed superior weight loss over Wegovy (semaglutide) in complete SURMOUNT-5 results published in The New England Journal of Medicine

Participants achieved an average weight loss of 20.2% with Zepbound vs. 13.7% with Wegovy In key secondary endpoints, Zepbound was superior to Wegovy across all weight reduction targets and ...

Weight-loss drugs fill a treatment gap for women with hormone disorder PCOS, doctors say

Women with polycystic ovary syndrome are increasingly turning to blockbuster weight-loss drugs from Eli Lilly and Novo ...
Everyday Health on MSN

New Obesity Drug Helped People Lose Nearly One-Third Their Body Weight

The clinical trial showed this experimental medication to be much more effective than any existing GLP-1 drug. But that much ...

Lilly’s experimental shot reduces body weight by 23% in study

A next-generation obesity shot from Eli Lilly & Co. helped patients lose almost a quarter of their body weight, potentially making the experimental drug the most potent weight loss medicine yet.

Biotech boss urges pharma to move on from ‘weight-loss Olympics’

Pharma companies need to move beyond the “weight loss Olympics” and focus on more durable treatments with fewer side effects, ...
KVIA

Ozempic face: The cosmetic concerns of rapid weight loss

Northwell Health reports that "Ozempic face" describes the facial changes from rapid weight loss using Ozempic, highlighting ...